Neuroleptic malignant syndrome (NMS) is a rare neurological condition associated with the use of antipsychotic medications. Autonomic dysfunction, or damage to the nerves that control involuntary ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
NMS Capital has promoted Daniel Schwartz to managing director and Jake Kinsley to vice president. Schwartz joined NMS in 2021 as a principal while Kinsley came on board in 2018 as an associate. New ...
WE REPORT A CASE INVOLVING AN 81-YEAR-OLD man with schizoaffective disorder who presented with neuroleptic malignant syndrome (NMS) after an increase in his neuroleptic dose. NMS, a rare but ...
LOS ANGELES, CA / ACCESS Newswire / May 12, 2025 / NMS Capital Group ("NMS") is proud to announce its inclusion in the Los Angeles Business Journal's 2024 list of Top Private Equity Firms, published ...
As we recently discussed, the SEC has a number of significant rule change proposals on the slate right now. One of those proposals involves splitting the old National Best Bid and Offer (NBBO) into ...
Neuroleptic malignant syndrome (NMS) is a reaction to some specific types of medications. It’s characterized by symptoms like very high fever, rigid muscles, and rapid heartbeat. Although rare, NMS is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback